Literature DB >> 17892972

Ethical considerations of fetal therapy.

Ray Noble1, Charles H Rodeck.   

Abstract

Fetal therapy raises ethical concerns in relation to the balance of potential benefit and harm, autonomy and informed consent, and the duties of the clinician to the pregnant women and fetus. Invasive therapy should be recommended only when it has a realistic chance of saving the life of the fetus and offspring or preventing serious and irreversible disease or disability. Clinicians should respect maternal choice and assessment of risk, particularly if the therapy might be only partially successful, leaving the offspring with a profound morbidity. Fetal therapy should not be undertaken without maternal consent; nor should it be presented coercively as an option to avoid a termination of pregnancy. Therapeutic procedures of unproven efficacy should be undertaken only with the voluntary informed consent of the pregnant woman and according to a clearly defined research protocol that has been approved by an appropriate research ethics committee and where appropriate support and counselling can be provided.

Entities:  

Mesh:

Year:  2007        PMID: 17892972     DOI: 10.1016/j.bpobgyn.2007.07.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  3 in total

1.  Abortion decisions as inclusion and exclusion criteria in research involving pregnant women and fetuses.

Authors:  Carson Strong
Journal:  J Med Ethics       Date:  2011-06-17       Impact factor: 2.903

2.  A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials.

Authors:  Saskia Hendriks; Christine Grady; David Wasserman; David Wendler; Diana W Bianchi; Benjamin E Berkman
Journal:  Am J Bioeth       Date:  2021-01-16       Impact factor: 11.229

3.  The fetal patient -- ethical aspects of fetal therapy.

Authors:  J Deprest; J Toelen; Z Debyser; C Rodrigues; R Devlieger; L De Catte; L Lewi; T Van Mieghem; G Naulaers; M Vandevelde; F Claus; K Dierickx
Journal:  Facts Views Vis Obgyn       Date:  2011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.